Biomedical Technologies Enhances Lipoprotein Manufacturing Capabilities
News Jun 01, 2015
Preparative ultracentrifuges are used in biology for gradient separations, where the molecules in a sample are separated using a substance of graduated density, such as salt gradients for proteins. The process is often gradual and involves many sequential steps to obtain the desired gradient. BT is now able to double its lipoprotein manufacturing capability and significantly reduce lead times for both standard and custom products.
The lipoprotein manufacturing process is now 24 hours a day, 7 days a week to meet customers' demands.
Kristy McGuire, Laboratory Manager, commented: 'We are committed to our customers and believe that investing in the second ultracentrifuge will enhance our manufacturing capabilities and reduce the lead time on custom products, ultimately resulting in our customers receiving a first class service that exceeds their expectations.
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE